$MRK , and low price/earnings ratios, Bill Alpert writes in this week's edition of Barron's. After lagging behind the market in 2019, stocks like Merck (MRK), Pfizer (PFE), and Eli Lilly (LLY) have outperformed the S&amp;P 500 index since the coronavirus disruption began, the author